May 30, 2022
Take it to the LIMIT
You know a vanguard study has been very successful when one of its key objectives – assessing recruitment potential – ...
Read More
May 25, 2022
COMPASS LTOLE supports dual pathway inhibition for vascular protection
PHRI’s COMPASS Long Term Open Label Extension (LTOLE) “further highlights and supports long-term use of [Factor Xa inhibitor anticoagulant] rivaroxaban,...
Read More
May 11, 2022
European Stroke Org’s young investigator award
PHRI Investigator Aristeidis Katsanos, a member of our stroke and brain health research program, has been given a Young Investigator...
Read More
May 9, 2022
Winners of transdisciplinary research grants
Three winners of the PHRI-based transdisciplinary research grant program in Hamilton, Canada (new this year) – called Transforming Tomorrow Today,...
Read More
May 3, 2022
PHRI pivotal in national heart failure research network
PHRI is one of six hubs of research in the new Canadian Heart Function Alliance (CHF Alliance) network launched today...
Read More
April 30, 2022
New cardiac defibrillator greatly reduced complications
ATLAS S-ICD RCT at PHRI led by Jeff Healey and Blandine Mondesert presented at Heart Rhythm 2022 found that S-ICD reduced lead-related complications for patients compared to TV-ICD.
Read More